Efficacy and cost-effectiveness of a therapist-assisted web-based intervention for depression and anxiety in patients with ischemic heart disease attending cardiac rehabilitation [eMindYourHeart trial]: a randomised controlled trial protocol.
Susanne S PedersenChristina M AndersenRobert AhmSøren J SkovbakkeRobin KokCharlotte HelmarkUffe K WiilThomas SchmidtKim Rose OlsenJacob HjelmborgAnn-Dorthe ZwislerLisbeth FrostholmPublished in: BMC cardiovascular disorders (2021)
To our knowledge, this is the first trial to evaluate both the efficacy and cost-effectiveness of a therapist-assisted eHealth intervention in patients with IHD and comorbid psychological distress as part of CR. Integrating screening for and treatment of depression and anxiety into standard CR may decrease dropout and facilitate better risk factor management, as it is presented as "one package" to patients, and they can access the eMindYourHeart program in their own time and at their own convenience. The trial holds a strong potential for improving the quality of care for an increasing population of patients with IHD and comorbid depression, anxiety or both, with likely benefits to patients, families, and society at large due to potential reductions in direct and indirect costs, if proven successful. Trial registration The trial was prospectively registered on https://clinicaltrials.gov/ct2/show/NCT04172974 on November 21, 2019 with registration number [NCT04172974].
Keyphrases
- study protocol
- phase iii
- end stage renal disease
- randomized controlled trial
- clinical trial
- phase ii
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- quality improvement
- prognostic factors
- peritoneal dialysis
- sleep quality
- depressive symptoms
- magnetic resonance
- computed tomography
- risk assessment
- magnetic resonance imaging
- smoking cessation